Besvil 200 Octacap is a prescription inhalation medicine used to treat asthma and chronic obstructive pulmonary disease (COPD). It is a combination of Fluticasone Furoate and Vilanterol, two active ingredients that work together to ease breathing difficulties. Fluticasone Furoate acts as a corticosteroid that reduces inflammation, redness, and swelling in the airways. Vilanterol is a long-acting bronchodilator that relaxes airway muscles, allowing air to flow freely in and out of the lungs. The combined effect helps relieve wheezing, shortness of breath, chest tightness, and coughing. It should be taken regularly as prescribed to maintain stable breathing and prevent flare-ups. Besvil 200 is not a rescue medicine for sudden asthma attacks and must be used under medical guidance.
Uses
- Allergic conditions
- Asthma
- Treatment of Chronic obstructive pulmonary disease (COPD)
Benefits of Besvil 200 Octacap
- Improves airflow by relaxing and opening the air passages in the lungs.
- Reduces inflammation and irritation in the respiratory tract for better long-term control.
- Prevents asthma and COPD symptoms such as wheezing, breathlessness, and coughing.
- Enhances breathing efficiency, helping patients perform daily activities comfortably.
- Lowers the risk of flare-ups and respiratory complications when used consistently.
How Besvil 200 Octacap works
Besvil 200 Octacap works through the dual action of Fluticasone Furoate and Vilanterol. Fluticasone Furoate reduces the body’s inflammatory response by blocking certain chemical messengers that cause swelling and mucus buildup in the airways. This decreases irritation and prevents airway narrowing. Vilanterol, on the other hand, binds to beta receptors in lung muscles and triggers relaxation, allowing smooth airflow into the lungs. Together, they provide long-term relief from breathing difficulty and maintain open air passages.
Side effects
- Headache
- Cough
- Fever
- Back pain
- Sinusitis
